About Biocogniv Inc

Biocogniv develops AI-powered predictive diagnostics to help frontline providers recognize acute conditions like sepsis before they become irreversible. Its clinOS™ software platform analyzes routine laboratory data, deploying models such as the FDA-designated Sepsis aiMarker™ to deliver real-time clinical alerts. The company primarily serves hospitals and health systems to reduce preventable deaths and improve care efficiency.

Company Classification

Customers

Customer	Success Story	Source
University of Texas Medical Branch	Conducted blinded, independent validation of Biocogniv's digital biomarker and deployed the real‑time cloud‑based clinOS™ platform to power over 1 million laboratory interpretations, supporting COVID‑19 testing and broader acute‑condition detection.
Baylor College of Medicine	Evaluated Biocogniv's AI-based biomarkers, recognizing their potential to detect acute conditions early and become part of the standard of care in emergency medicine.
Nice Try Sign up to Ethos to access the full customer list Sign up to Ethos	Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.	Source
Another Company	Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.	Source
One More Company	Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Sunt in culpa qui officia deserunt mollit anim id est laborum.	Source